, India
Stock photo. Credits to Unsplash.

India insurance regulator proposes to allow private equity funds in insurance

Private equity funds may invest as a promoter or an investor.

The Insurance Regulatory and Development Authority of India is proposing a draft to allow private equity funds to invest in insurance and reinsurance as either a promoter or investor.

A private equity fund may only invest as a ‘promoter’ only if it has completed 10 years of operations and the funds raised by the fund including its group entity or entities are around $500m or more. It must also have investible funds available with the PE fund to be not less than $100m and that it has invested in the financial sector in India or other jurisdictions.

ALSO READ: India sets ambitious goal to be sixth largest insurance market globally

Additionally, the amendment also proposes that an investment made in an insurance or reinsurance entity, in the capacity of promoter or investor at the time of or before the grant of certificate registration (R3), shall have a locked-in period of five years. An investment made within five years after the grant of the R3 status, meanwhile, will have a lock-in period of five years or eight years from the grant of the R3, whichever is earlier.

The IRDAI has asked stakeholders and the general public to share views and comments on the draft by 3 November.

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.